Status:
COMPLETED
Effect of Calcium/Vitamin D Supplementation on Body Weight and Fat Loss.
Lead Sponsor:
Laval University
Collaborating Sponsors:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Obesity
Overweight
Eligibility:
FEMALE
30-50 years
Phase:
PHASE4
Brief Summary
The aim of this study was to assess the effect of calcium/vitamin D supplementation (Caltrate 600 +D®) on body weight loss during a weight-reducing program
Detailed Description
The effect of a calcium supplementation on body weight loss is inconclusive and some studies have suggested that adequate calcium intake can have a favourable effect on some metabolic variables. The o...
Eligibility Criteria
Inclusion
- Daily calcium intake below 800mg/day
- Stable body weight
- Body mass index (BMI) between 27-40kg/m2
- Less than 3 periods of 20 minutes of physical exercise/week
- General good health
- Normal blood pressure values
- Normal cholesterol levels
- Normal thyroid hormone levels
- No participation in another clinical trial within 6 months of screening
- Coffee consumption ≤ 5 cups/day.
Exclusion
- Breast feeding, pregnant or menopaused women
- Use of calcium supplements within 30 days of screening
- Cholesterol levels requiring pharmaceutical treatment
- Smoking
- Use of medication that could affect body weight
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
End Date :
July 1 2005
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00353054
Start Date
January 1 2003
End Date
July 1 2005
Last Update
July 17 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Université Laval
Québec, Quebec, Canada, G1K 7P4